Enanta Pharmaceuticals, Inc.
← Back to ENTA Overview

Enanta Pharmaceuticals, Inc. (ENTA)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-7.02

Financial Fundamentals

ENTAQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2011-09-30-108.19
2011-12-31-12.27
2012-03-3118.67
2012-06-30-9.99
2012-09-302.48
2012-12-3125.26
2013-03-31-11.32
2013-06-30-11.68
2013-09-30-13.64
2013-12-31-22.73
2014-03-31-35.71
2014-06-303.99
2014-09-30-36.64
2014-12-315.63
2015-03-314.97
2015-06-3086.52
2015-09-3030.12
2015-12-315.94
2016-03-31-81.58
2016-06-30-97.22
2016-09-30-70.25
2016-12-31-32.21
2017-03-31-27.50
2017-06-30-20.44
2017-09-306.13
2017-12-3124.05
2018-03-3131.12
2018-06-3027.60
2018-09-3014.91
2018-12-3113.21
2019-03-31112.76
2019-06-3059.74
2019-09-3031.96
2019-12-3122.71
2020-03-31-42.86
2020-06-30-17.68
2020-09-30-7.84
2020-12-31-25.67
2021-03-31-11.31
2021-06-30-9.25
2021-09-30-11.64
2021-12-31-12.63
2022-03-31-10.92
2022-06-30-7.72
2022-09-30-10.13
2022-12-31-8.37
2023-03-31-5.65
2023-06-30-2.88
2023-09-30-2.10
2023-12-31-1.49
2024-03-31-2.89
2024-06-30-3.05
2024-09-30-1.90
2024-12-31-1.37
2025-03-31-1.30
2025-06-30-2.20
2025-09-30-3.44
2025-12-31-7.04
2026-03-31-7.02

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.

Enanta Pharmaceuticals, Inc. (ENTA) P/E Ratio History & Valuation Cycles